Curis (CRIS) Accumulated Expenses (2010 - 2026)
Curis (CRIS) reported Accumulated Expenses of $7.0 million for Q1 2026, up 8.1% on a YoY basis from $6.5 million in Q1 2025, and down 3.73% quarter-over-quarter from $7.3 million in Q4 2025.
Curis (CRIS) Accumulated Expenses (2010 - 2026) Analysis & Trends
Curis has reported Accumulated Expenses for 17 years, with the latest figure at $7.0 million in Q1 2026.
- For the quarter ending Q1 2026, Accumulated Expenses rose 8.1% year-over-year to $7.0 million; the trailing twelve-month figure through Mar 2026 stood at $7.0 million (up 8.1% YoY), and the FY2025 full-year result was $7.3 million, up 2.29% from the prior year.
- Accumulated Expenses for Q1 2026 stood at $7.0 million, down from $7.3 million in the prior quarter.
- The five-year high for Accumulated Expenses was $9.0 million in Q4 2023, with the low at $4.2 million in Q1 2023.
- Historically, Accumulated Expenses has averaged $6.6 million across 5 years, with a median of $6.7 million in 2024.
- Annual changes were most pronounced in 2022 — Accumulated Expenses jumped 122.41% — and 2024, when it retreated 21.34%.
- Curis' Accumulated Expenses stood at $5.7 million in 2022, then surged by 59.18% to $9.0 million in 2023, then dropped by 21.34% to $7.1 million in 2024, then gained by 2.29% to $7.3 million in 2025, then fell by 3.73% to $7.0 million in 2026.
- The last three Accumulated Expenses figures came in at $7.0 million (Q1 2026), $7.3 million (Q4 2025), and $7.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | Curis | 8.58 Mn | -6.42 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.00 Mn |
| Dec 31, 2025 | 7.27 Mn |
| Sep 30, 2025 | 7.29 Mn |
| Jun 30, 2025 | 6.66 Mn |
| Mar 31, 2025 | 6.48 Mn |
| Dec 31, 2024 | 7.11 Mn |
| Sep 30, 2024 | 8.14 Mn |
| Jun 30, 2024 | 6.74 Mn |
| Mar 31, 2024 | 6.33 Mn |
| Dec 31, 2023 | 9.04 Mn |
| Sep 30, 2023 | 7.23 Mn |
| Jun 30, 2023 | 5.78 Mn |
| Mar 31, 2023 | 4.25 Mn |
| Dec 31, 2022 | 5.68 Mn |
| Sep 30, 2022 | 6.88 Mn |
| Jun 30, 2022 | 5.58 Mn |
| Mar 31, 2022 | 4.59 Mn |
| Dec 31, 2021 | 6.34 Mn |
| Sep 30, 2021 | 5.31 Mn |
| Jun 30, 2021 | 3.18 Mn |